Abstract
Chronic GvHD is the leading cause of non-relapse mortality in recipients of hematopoietic cell transplantation. Although the benefit of physical therapy (PT) has been reported in some GvHD studies, a literature gap is identified in demonstrating the exact role of different types of PT interventions and their impact on GvHD outcomes. An electronic search was undertaken using 13 peer-reviewed databases from 1994 to 2016. JADAD scoring method was used to score the quality of articles. PT interventions utilized for non-GvHD aspects of transplantation were excluded. Out of the 4775 articles on the electronic search, 297 articles were reviewed out of which 3 fulfilled the selection criteria. Moderately high evidence for effectiveness of supervised PT intervention was found, whereas moderate evidence for a self-administered exercise program was established. No safety concerns with PT were observed in any of the studies, however none of the studies were conducted to directly evaluate safety and effectiveness specifically in GvHD patients. PT is a safe but understudied therapy for GvHD. Limited evidence on the effectiveness of most PT interventions is available through randomized control trials. Well-designed trials are urgently needed for musculoskeletal GvHD especially with focused PT interventions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Copelan EA . Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813–1826.
Flowers ME, Martin PJ . How we treat chronic graft-versus-host disease. Blood 2014; 125: 606–615.
Martin P, Counts G, Appelbaum F, Lee S, Sanders J, Deeg H et al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol 2010; 28: 1011–1016.
Pidala J, Perez L, Anasetti C . Have we improved in preventing and treating acute GVHD? Curr Opin Hematol 2011; 18: 408–413.
Lee S, Kim H, Ho V, Cutler C, Alyea E, Soiffer R et al. Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transplant 2006; 38: 30–310.
Flowers M, Inamoto Y, Carpenter P, Lee S, Kiem H, Petersdorf E et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus host disease according to National Institutes of Health consensus criteria. Blood 2011; 117: 3214–3219.
Anasetti C, Logan B, Lee S, Waller E, Weisdorf D, Wingard J et al. Peripheral blood stem cells versus bone marrow from unrelated donors. N Engl J Med 2012; 367: 1487–1496.
Stem Cell Trialists’ Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005; 23: 5074–5087.
Vogelsang GB . How I treat chronic graft-versus-host disease. Blood 2001; 97: 1196–1201.
George B, Danda D, Chandy M . Polymyositis–an unusual manifestation of chronic graft-versus-host disease. Rheumatol Int 2001; 20: 169–170.
Linhares YPL, Pavletic S, Gale RP . Chronic GVHD: Where are we Where do we want to be Will immunomodulatory drugs help. Bone Marrow Transplant 2013; 48: 203–209.
Carpenter P, Kitko C, Elad S, Flowers M, Gea-Banacloche J, Halter J et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 2015; 21: 1167–1187.
Jadad A, Moore R, Carroll D, Jenkinson C, Reynolds D, Gavaghan D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1–12.
Hovi L, Kurimo M, Taskinen M, Vettenranta J, Vettenranta K, Saarinenpihkala U et al. Suboptimal long-term physical performance in children and young adults after pediatric allo-SCT. Bone Marrow Transplant 2009; 45: 738–745.
Wiskemann J, Kuehl R, Dreger P, Huber G, Kleindienst N, Ulrich C et al. Physical exercise training versus relaxation in allogeneic stem cell transplantation (PETRA Study)–rationale and design of a randomized trial to evaluate a yearlong exercise intervention on overall survival and side effects after allogeneic stem cell transplantation. BMC Cancer 2015; 15: 619.
Baumann F, Zopf E, Nykamp E, Kraut L, Schüle K, Elter T et al. Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention. Eur J Haematol 2011; 87: 148–156.
Wiskemann J, Dreger P, Schwerdtfeger R, Bondong A, Huber G, Kleindienst N et al. Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. Blood 2010; 117: 2604–2613.
Jarden M, Baadsgaard MT, Hovgaard DJ, Boesen E, Adamsen L . 'A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT'. Bone Marrow Transplant 2009; 43: 725–737.
Bjordal JM, Johnson MI, Ljunggreen AE . Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption. A meta-analysis with assessment of optimal treatment parameters for postoperative pain. Eur J Pain 2003; 7: 181–188.
Singh P, Chaturvedi A . Complementary and alternative medicine in cancer pain management: a systematic review. Indian J Palliat Care 2015; 21: 105–115.
Johnson MI, Paley CA, Howe TE . Transcutaneous electrical nerve stimulation for acute pain. Cochrane Database Syst Rev 2015; 15:(6) doi:10.1002/14651858.CD006142:CD006142.
Melzack R, Wall PD . Pain mechanisms: a new theory. Science 1965; 150: 971–978.
Johnson M . Transcutaneous electrical nerve stimulation: mechanisms, clinical application and evidence. Rev Pain 2007; 1: 7–11.
Vance C, Dailey D, Rakel B, Sluka K . Using TENS for pain control: the state of the evidence. Pain Manag 2014; 4: 197–209.
Elhag M, Coghlan K, Christmas P, Harvey W, Harris M . The anti-inflammatory effects of dexamethasone and therapeutic ultrasound in oral surgery. Br J Oral Maxillofac Surg 1985; 23: 17–23.
Speed CA . Therapeutic ultrasound in soft tissue lesions. Rheumatology 2001; 40: 1331–1336.
Miller D, Smith N, Bailey M, Czarnota G, Hynynen K, Makin I et al. Overview of therapeutic ultrasound applications and safety considerations. J Ultrasound Med 2012; 31: 623–634.
Watson T . 'Ultrasound in contemporary physiotherapy practice'. Ultrasonics 2008; 48: 321–329.
Li J, Chang W, Lin J, Ruaan R, Liu H, Sun J et al. Cytokine release from osteoblasts in response to ultrasound stimulation. Biomaterials 2003; 24: 2379–2385.
Castro-Sanchez A, Mataran-Penarrocha G, Arroyo-Morales M, Saavedra-Hernandez M, Fernandez-SOLA C, Moreno-Lorenzo C et al. Effects of myofascial release techniques on pain, physical function, and postural stability in patients with fibromyalgia: a randomized controlled trial. Clin Rehabil 2011; 25: 800–813.
Beardsley C, Škarabot J . Effects of self-myofascial release: a systematic review. J Bodyw Mov Ther 2015; 19: 747–758.
Simmonds N, Miller P, Gemmell H . A theoretical framework for the role of fascia in manual therapy. J Bodyw Mov Ther 2012; 16: 83–93.
Rosenbaum TY, Owens A . Continuing medical education: the role of pelvic floor physical therapy in the treatment of pelvic and genital pain-related sexual dysfunction (CME). J Sex Med 2008; 5: 513–523.
Chung C, Sargent R, Chung N, Lacey J, Wakabayashi M . Graft-versus-host disease–associated vulvovaginal symptoms after bone marrow transplantation. Biol Blood Marrow Transplant 2016; 22: 378–379.
Pizzari T, Davidson M . Health Outcomes can be improved by implementing an occupational physiotherapy provider programme. Physiother Res Int 2013; 18: 47–54.
Kirchhoff AC, Leisenring W, Syrjala KL . Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation. J Cancer Surviv 2010; 4: 33–44.
Yildiz Kabak V, Duger T, Uckan Cetinkaya D . Investigation of the effects of an exercise program on physical functions and activities of daily life in pediatric hematopoietic stem cell transplantation. Pediatr Blood Cancer 2016; 63: 1643–1648.
Hashmi S, Carpenter P, Khera N, Tichelli A, Savani B . Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors. Biol Blood Marrow Transplant 2015; 21: 225–232.
Steinberg A, Asher A, Bailey C, Fu J . The role of physical rehabilitation in stem cell transplantation patients. Support Care Cancer 2015; 23: 2447–2460.
Acknowledgements
Author contributions
JM and SKH wrote the manuscript. All authors contributed substantially to the conception, acquisition, analysis and interpretation of the data for the work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Mohammed, J., Savani, B., El-Jawahri, A. et al. Is there any role for physical therapy in chronic GvHD?. Bone Marrow Transplant 53, 22–28 (2018). https://doi.org/10.1038/bmt.2017.155
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2017.155
This article is cited by
-
‘To treat or not to treat’: raising awareness on the effects of graft versus host disease drugs on musculoskeletal system
Bone Marrow Transplantation (2018)